Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
45
IBB Quote, Financials, Valuation and Earnings
Last price:
$134.57
Seasonality move
:
4.27%
Day range:
$133.94 - $135.49
52-week range:
$123.60 - $150.57
Dividend yield:
0.29%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
509.4K
Avg. volume:
1.3M
1-year change:
-2.03%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IBB
iShares Biotechnology ETF
|
$134.09 | -- | -- | -- | $0.12 | 0.29% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$168.06 | -- | -- | -- | $1.17 | 0.7% | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$22.17 | -- | -- | -- | $0.06 | 1.11% | -- |
|
IHI
iShares US Medical Devices ETF
|
$59.52 | -- | -- | -- | $0.03 | 0.46% | -- |
|
IYH
iShares US Healthcare ETF
|
$61.16 | -- | -- | -- | $0.16 | 1.18% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IBB
iShares Biotechnology ETF
|
-- | 1.306 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 1.243 | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 1.162 | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | 1.267 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -0.715 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IBB
iShares Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
IHI
iShares US Medical Devices ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
iShares Biotechnology ETF vs. Competitors
-
Which has Higher Returns IBB or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to iShares Biotechnology ETF's net margin of --. iShares Biotechnology ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBiShares Biotechnology ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About IBB or FBT?
iShares Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Biotechnology ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe iShares Biotechnology ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings IBBiShares Biotechnology ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is IBB or FBT More Risky?
iShares Biotechnology ETF has a beta of 0.794, which suggesting that the stock is 20.628% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.732, suggesting its less volatile than the S&P 500 by 26.822%.
-
Which is a Better Dividend Stock IBB or FBT?
iShares Biotechnology ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.29%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.7% to investors and pays a quarterly dividend of $1.17 per share. iShares Biotechnology ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBB or FBT?
iShares Biotechnology ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. iShares Biotechnology ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, iShares Biotechnology ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Biotechnology ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBiShares Biotechnology ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns IBB or IBBQ?
Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to iShares Biotechnology ETF's net margin of --. iShares Biotechnology ETF's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBiShares Biotechnology ETF-- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -
What do Analysts Say About IBB or IBBQ?
iShares Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Biotechnology ETF has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe iShares Biotechnology ETF is more attractive than Invesco Nasdaq Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBiShares Biotechnology ETF0 0 0 IBBQInvesco Nasdaq Biotechnology ETF0 0 0 -
Is IBB or IBBQ More Risky?
iShares Biotechnology ETF has a beta of 0.794, which suggesting that the stock is 20.628% less volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IBB or IBBQ?
iShares Biotechnology ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.29%. Invesco Nasdaq Biotechnology ETF offers a yield of 1.11% to investors and pays a quarterly dividend of $0.06 per share. iShares Biotechnology ETF pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBB or IBBQ?
iShares Biotechnology ETF quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. iShares Biotechnology ETF's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, iShares Biotechnology ETF's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Biotechnology ETF is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBiShares Biotechnology ETF-- -- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- --
-
Which has Higher Returns IBB or IHI?
iShares US Medical Devices ETF has a net margin of -- compared to iShares Biotechnology ETF's net margin of --. iShares Biotechnology ETF's return on equity of -- beat iShares US Medical Devices ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBiShares Biotechnology ETF-- -- -- IHIiShares US Medical Devices ETF-- -- -- -
What do Analysts Say About IBB or IHI?
iShares Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Medical Devices ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Biotechnology ETF has higher upside potential than iShares US Medical Devices ETF, analysts believe iShares Biotechnology ETF is more attractive than iShares US Medical Devices ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBiShares Biotechnology ETF0 0 0 IHIiShares US Medical Devices ETF0 0 0 -
Is IBB or IHI More Risky?
iShares Biotechnology ETF has a beta of 0.794, which suggesting that the stock is 20.628% less volatile than S&P 500. In comparison iShares US Medical Devices ETF has a beta of 0.880, suggesting its less volatile than the S&P 500 by 12.031%.
-
Which is a Better Dividend Stock IBB or IHI?
iShares Biotechnology ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.29%. iShares US Medical Devices ETF offers a yield of 0.46% to investors and pays a quarterly dividend of $0.03 per share. iShares Biotechnology ETF pays -- of its earnings as a dividend. iShares US Medical Devices ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBB or IHI?
iShares Biotechnology ETF quarterly revenues are --, which are smaller than iShares US Medical Devices ETF quarterly revenues of --. iShares Biotechnology ETF's net income of -- is lower than iShares US Medical Devices ETF's net income of --. Notably, iShares Biotechnology ETF's price-to-earnings ratio is -- while iShares US Medical Devices ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Biotechnology ETF is -- versus -- for iShares US Medical Devices ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBiShares Biotechnology ETF-- -- -- -- IHIiShares US Medical Devices ETF-- -- -- --
-
Which has Higher Returns IBB or IYH?
iShares US Healthcare ETF has a net margin of -- compared to iShares Biotechnology ETF's net margin of --. iShares Biotechnology ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IBBiShares Biotechnology ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About IBB or IYH?
iShares Biotechnology ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that iShares Biotechnology ETF has higher upside potential than iShares US Healthcare ETF, analysts believe iShares Biotechnology ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings IBBiShares Biotechnology ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is IBB or IYH More Risky?
iShares Biotechnology ETF has a beta of 0.794, which suggesting that the stock is 20.628% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.582, suggesting its less volatile than the S&P 500 by 41.766%.
-
Which is a Better Dividend Stock IBB or IYH?
iShares Biotechnology ETF has a quarterly dividend of $0.12 per share corresponding to a yield of 0.29%. iShares US Healthcare ETF offers a yield of 1.18% to investors and pays a quarterly dividend of $0.16 per share. iShares Biotechnology ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IBB or IYH?
iShares Biotechnology ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. iShares Biotechnology ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, iShares Biotechnology ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for iShares Biotechnology ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IBBiShares Biotechnology ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
